Panacea Biotech Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Panacea Biotech Quarterly Results    (PANB)

Here are the latest quarterly results of Panacea Biotech. For more details, see the Panacea Biotech financial fact sheet and Panacea Biotech share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Panacea Biotech Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,6769511,1861,139293248210555 
Other income Rs m1273333411111812 
Turnover Rs m1,8029841,2191,180304260218567 
Expenses Rs m1,4611,1351,2899651,406373528474 
Gross profit Rs m21523-5781732,495-125-47282 
Depreciation Rs m13813713613684716865 
Interest Rs m25726126828223541317 
Profit before tax Rs m-53-342-948-2042,187-188-54511 
Tax Rs m3227272726262423 
Profit after tax Rs m-86-368-975-2302,161-214-569-13 
Gross profit margin %12.82.4-48.715.2852.7-50.2-225.114.7 
Effective tax rate %-60.7-7.8-2.8-13.11.2-13.6-4.4220.0 
Net profit margin %-5.1-38.7-82.2-20.2738.4-86.1-271.4-2.3 
Diluted EPS Rs -1.4 -6.0 -15.9 -3.8 35.3 -3.5 -9.3 -0.2  
Diluted EPS (TTM) Rs -11.7 -9.9 -24.9 -27.1 9.6 12.1 18.7 22.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Panacea Biotech 3QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   AJANTA PHARMA  UNICHEM LAB  PFIZER  AMAR REMEDIES  TTK HEALTHCARE  

Compare PANACEA BIOTECH With:   AJANTA PHARMA  UNICHEM LAB  PFIZER  AMAR REMEDIES  TTK HEALTHCARE  

Compare PANACEA BIOTECH With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 661 Points, Nifty Ends Above 14,500; M&M and Bajaj Finserv Top Gainers(Closing)

Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.

Views on news

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This... (Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

The Indian Real Estate Party Has Just Begun (Profit Hunter)

Apr 1, 2021

A favourable demand supply scenario makes a strong case for real estate prices.

The Dilemma of Investing in Bharti Airtel Views On News (Views On News)

Apr 1, 2021

Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Apr 13, 2021 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - TEVA PHARMA COMPARISON

COMPARE PANACEA BIOTECH WITH

MARKET STATS